Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15- year experience

World Journal of Gastroenterology

Volumn 10, Issue 4, 2004, Pages 471-475

  Mu, De Qing ^a   Peng, You Shu ^a   Xu, Qiao Jian ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN;

CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CHRONIC PANCREATITIS; CODON; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FECES ANALYSIS; GENE MUTATION; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; MEDLINE; NEEDLE BIOPSY; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 1542314907     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i4.471     Document Type: Review

References (48)

1. Yeaton P, Sears RJ, Ledent T, Salmon T, Kiss R, Decaestecker C. Discrimination between chronic pancreatitis and pancreatic adenocarcinoma using artificial intelligence-related algorithms based on image cytometry-generated variables. Cytometry 1998; 32: 309-316
2. Lee JG, Leung J. Tissue sampling at ERCP in suspected pancreatic cancer. Gastrointest Endosc Clin N Am 1998; 8: 221-235
3. Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134: 459-464
4. Afify AM, al-Khafaji BM, Kim B, Scheiman JM. Endoscopic ultrasound-guided fine needle aspiration of the pancreas. Diagnostic utility and accuracy. Acta Cytol 2003; 47: 341-348
5. Motojima K, Kohara N, Furui J, Terada M, Tsunoda T, Nagata Y, Urano K. Detection of point mutation of Kirsten ras oncogene in pancreatic carcinoma by polymerase chain reaction. Nippon Geka Gakkai Zasshi 1991; 92:453-458
6. Tada M, Omata M, Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991; 100: 233-238
7. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Kloppel G. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102: 230-236
8. Orth M, Gansauge F, Gansauge S, Beger HG, Adler G, Schmid RM. K-ras mutations at codon 12 are rare events in chronic pancreatitis. Digestion 1998; 59: 120-124
9. Yamada T, Nakamori S, Ohzato H, Oshima S, Aoki T, Higaki N, Sugimoto K, Akagi K, Fujiwara Y, Nishisho I, Sakon M, Gotoh M, Monden M. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin Cancer Res 1998; 4: 1527-1532
10. Castells A, Puig P, Mora J, Boadas J, Boix L, Urgell E, Sole M, Capella G, Lluis F, Fernandez-Cruz L, Navarro S, Farre A. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol 1999; 17: 578-584
11. Mulcahy H, Farthing MJ. Diagnosis of pancreatico-biliary malignancy:detection of gene mutations in plasma and stool. Ann Oncol 1999; 10(Suppl 4): 114-117
12. Theodor L, Melzer E, Sologov M, Idelman G, Friedman E, Bar-Meir S. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum. Dig Dis Sci 1999; 44: 2014-2019
13. Sawabu N, Watanabe H, Yamaguchi Y, Okai T. Mutations of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma. Nippon Rinsho 1995; 53: 511-517
14. Watanabe H, Sawabu N, Songur Y, Yamaguchi Y, Yamakawa O, Satimura Y, Ohta H, Motoo Y, Okai T, Wakabayashi T. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas 1996; 12: 18-24
15. Watanabe H, Yamaguchi Y, Ha A, Hu YX, Motoo Y, Okai T, Yoshimura T, Sawabu. N. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay. Pancreas 1998; 17: 341-347
16. Kimura W, Zhao B, Futakawa N, Muto T, Makuuchi M. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas. Hepatogastroenterology 1999; 46: 532-539
17. Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, Languille O, Roland J, Bernaudin JF. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 1993; 85: 2008-2012
18. Pabst B, Arps S, Binmoeller K, Thul R, Walsemann G, Fenner C, Klapdor R. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates. Anticancer Res 1999; 19: 2481-2483
19. Urgell E, Puig P, Boadas J, Capella G, Queralto JM, Boluda R, Antonijuan A, Farre A, Lluis F, Gonzalez-Sastre F, Mora J. Prospective evaluation of the contribution of K-ras mutational analysis and CA19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer. Eur J Cancer 2000; 36: 2069-2075
20. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54: 3568-3573
21. Berndt C, Haubold K, Wenger F, Brux B, Muller J, Bendzko P, Hillebrand T, Kottgen E, Zanow J. K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic disease. Clin Chem 1998; 44: 2103-2107
22. Wenger FA, Zieren J, Peter FJ, Jacobi CA, Muller JM. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis. Langenbecks Arch Surg 1999; 384: 181-186
23. Barbacid M. Ras genes. Annu Rev Biochem 1987; 56: 779-827
24. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vires M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987, 327: 293-297
25. Cerny WL, Mangold KA, Scarpelli DG. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 1992; 52:4507-4513
26. Luttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic,and metaplastic ductal epithelium. Cancer 1999; 85: 1703-1710
27. Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Iwafuchi M, Yamano M, Kijima H, Saito T. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma. Jpn J Cancer Res 1999; 90: 841-848
28. Tabate T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993; 14: 237-244
29. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996; 110: 227-231
30. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437
31. Karlson BM, Ekbom A, Josefsson S, McLaughlin JK, Fraumeni JF Jr, Nyren O. The risk of pancreatic cancer following pancreatitis: an association duo to confounding? Gastroenterology 1997; 113: 587-592
32. Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1996; 124: 1014-1015
33. Boadas J, Mora J, Urgell E, Puig P, Roca M, Cusso X, Capella G, Lluis F, Farre A. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol 2001; 13: 1141-1142
34. Queneau PE, Adessi GL, Thibault P, Cleau D, Heyd B, Mantion G, Carayon P. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol 2001; 96: 700-704
35. Lohr M, Muller P, Mora J, Brinkmann B, Ostwald C, Farre A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capella G, Liebe S. P53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc 2001; 53: 734-743
36. Furuya N, Kawa S, Akamatsu T, Furihata K. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 1997; 113: 593-598
37. Nakaizumi A, Uehera H, Takenaka A, Uedo N, Sakai N, Yano H, Ohigashi H, Ishikawa O, Ishiguro S, Sugano K, Tatsuta M. Diagnosis of pancreatic cancer by cytology and mesurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. Hepatogastroenterology 1999; 46: 31-37
38. Gansauge S, Schmid RM, Muller J, Alder G, Mattfeldt T, Berger HG. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg 1998; 85: 1015
39. Van Laethem JL, Vertongen P, Deviere J, Van Rampelbergh J, Rickaert F, Cremer M, Robberecht P. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut 1995; 36: 781-787
40. Watanabe H, Sawabu N, Ohta H, Satomura Y, Yamakawa O, Motoo Y, Okai T, Takahashi H, Wakabayashi T. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res 1993; 84: 961-965
41. Tada M, Omata M, Kawai S, Saisho H, Ohto, M, Saiki RK, Sninsky JJ. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993; 53: 2472-2474
42. Pugliese V, Pujic N, Saccomanno, S, Gatteschi B, Pera C, Aste H, Ferrara GB, Nicolo G. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and K-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001; 54: 595-599
43. Matsubayashi H, Watanabe H, Ajioka Y, Nishikura K, Yamano M, Seki T, Saito T, Matsubayashi T. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis. Pancreas 2000; 21: 77-85
44. Tada M, Komatsu Y, Kawabe T, Sasahira N, Isayama H, Toda N, Shiratori Y, Omata M. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002; 97: 2263-2270
45. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63: 2649-2657
46. Myung SJ, Kim MH, KimYS, Kim HJ, Park ET, Yoo KS, Lim BC, Wan SED, Lee SK, Min YT, Kim JY. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation. Gastrointest Endosc 2000; 51: 708-713
47. Gerdes B, Ramaswamy A, Kersting M, Ernst M, Lang S, Schuermann M, Wild A, Bartsch DK. P16(INK4a) alterations in chronic pancreatic-indicator for high-risk lesions for pancreatic cancer. Surgery 2001; 129: 490-497
48. Lu X, Xu T, Qian J. An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer. Zhonghua Yixue Zazhi 2001; 81: 1050-1053